Overview

A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants

Status:
Completed

Trial end date:
2019-12-19

Target enrollment:

Participant gender:

Summary

An open-label, fixed-sequence, 2-period study to investigate the effect of multiple oral doses of itraconazole on a single oral dose of PF-06700841 PK in healthy participants. The study will consist of two treatment periods in one fixed sequence.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Hydroxyitraconazole
Itraconazole
PF-06700841